Clinical Trial Update: Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Iomab-B to conventional care in older patients with active, relapsed or refractory acute myeloid leukemia is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Bone Marrow Transplant
• Leukemia Acute Myelogenous
• Leukemia Acute Myeloid
• Leukemia Myeloid Acute
• Myelogenous Leukemia
• Myelogenous Leukemia Acute
• Myeloid Leukemia Acute

Drugs mentioned

• Iomab-B (null)

Snippet

Sponsor: Actinium Pharmaceuticals | Conditions: Acute Myeloid Leukemia, Leukemia, Acute Myeloid | Phase 3 | Status: ACTIVE_NOT_RECRUITING